Norges Bank
MRSN

Norges Bank’s Mersana Therapeutics MRSN Stock Holding History

Norges Bank’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-536
Closed -$357K – 2174
2020
Q4 		$357K Hold
536
– – ﹤0.01% 2093
2020
Q3 		$250K Buy
+536
New +$271K ﹤0.01% 2112
2018
Q2 		– Sell
-800
Closed -$315K – 2156
2018
Q1 		$315K Hold
800
– – ﹤0.01% 2103
2017
Q4 		$329K Hold
800
– – ﹤0.01% 2100
2017
Q3 		$346K Hold
800
– – ﹤0.01% 2108
2017
Q2 		$279K Buy
+800
New +$277K ﹤0.01% 2105

Other funds holding MRSN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return